Zobrazeno 1 - 10
of 59
pro vyhledávání: '"Ayaka, Tanaka"'
Publikováno v:
Clinical Case Reports, Vol 12, Iss 8, Pp n/a-n/a (2024)
Key Clinical Message When the chest radiograph of a young patient shows lung hyperlucency, it is important to obtain a detailed clinical history of any previous episodes of childhood infection. Previous chest radiographs should be reviewed to determi
Externí odkaz:
https://doaj.org/article/74e9e34dc2bb4c2d98b1530bd5b27bd6
Publikováno v:
Respirology Case Reports, Vol 12, Iss 6, Pp n/a-n/a (2024)
Abstract Several reports have described dupilumab‐induced eosinophilic pneumonia (EP) after treatment with dupilumab in patients with type 2 inflammatory disease. Other reports have suggested the efficacy of dupilumab for chronic EP (CEP). Whether
Externí odkaz:
https://doaj.org/article/717873edf1ff4d6a90e588a885d0c722
Autor:
Masamitsu Hamakawa, Machiko Arita, Hiroshi Takahashi, Akihiko Amano, Nobuyoshi Hamao, Ayaka Tanaka, Akihiro Ito, Tadashi Ishida
Publikováno v:
Respiratory Medicine Case Reports, Vol 52, Iss , Pp 102142- (2024)
The efficacy of mepolizumab as an alternative to glucocorticoids for treating idiopathic chronic eosinophilic pneumonia (ICEP) has been reported. However, various questions remain unanswered, such as the most appropriate dose and dosage interval of m
Externí odkaz:
https://doaj.org/article/f46a7bea03f2423daad3960338e08b0e
Autor:
Takeshi Matsumoto, Yumiko Sakurai, Noriyuki Tashima, Tomoya Matoba, Akiko Kaneko, Takahiro Fujiki, Yusuke Kusakabe, Emi Nakayama, Ayaka Tanaka, Mayuko Tashima, Naoki Yamamoto, Kensaku Aihara
Publikováno v:
Respirology Case Reports, Vol 12, Iss 1, Pp n/a-n/a (2024)
Abstract The efficacy and safety of the combination of biologic therapies remain unclear with an ineffective and insufficient single biologic for managing asthma. Herein, we report two cases using dual biologics for severe asthma and atopic dermatiti
Externí odkaz:
https://doaj.org/article/654cc15de8cf45e4866ffa78d732fa48
Autor:
Takeshi Matsumoto, Akiko Kaneko, Yusuke Kusakabe, Emi Nakayama, Ayaka Tanaka, Naoki Yamamoto, Kensaku Aihara, Shinpachi Yamaoka, Michiaki Mishima
Publikováno v:
Respirology Case Reports, Vol 10, Iss 10, Pp n/a-n/a (2022)
Abstract Immune checkpoint inhibitors (ICIs) for malignant lesions are associated with immune‐related adverse events (irAEs), but reports about severe eosinophilia induced by ICIs are scarce. A 73‐year‐old man with lung squamous cell carcinoma
Externí odkaz:
https://doaj.org/article/9899d96e423f4c36bd32d53083fe83f7
Autor:
Takeshi Matsumoto, Akiko Kaneko, Takahiro Fujiki, Yusuke Kusakabe, Emi Nakayama, Ayaka Tanaka, Naoki Yamamoto, Kensaku Aihara, Shinpachi Yamaoka, Michiaki Mishima
Publikováno v:
Respiratory Investigation. 61:409-417
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::01f94c9f63719afc6bb0ed027fd9798f
https://doi.org/10.1016/j.resinv.2023.03.010
https://doi.org/10.1016/j.resinv.2023.03.010
Publikováno v:
Journal of Cutaneous Immunology and Allergy, Vol 2, Iss 5, Pp 128-134 (2019)
Abstract Objectives The effect of rupatadine, a novel H1 antihistamine with platelet‐activating factor antagonist activity, had been demonstrated for itching in Japanese patients with chronic spontaneous urticaria, dermatitis, or pruritus in a 12
Externí odkaz:
https://doaj.org/article/14440ba167dc4073a22a7663a9b64673
Publikováno v:
Allergology International, Vol 68, Iss 2, Pp 207-215 (2019)
Background: Rupatadine is a novel non-sedating second-generation H1-antihistamine with antiplatelet-activating factor activity, first marketed in Spain in 2003. It is used for treating allergic rhinitis in more than 80 countries. This study investiga
Externí odkaz:
https://doaj.org/article/ac68ad17d9dd4a018c630c82321e6382
Publikováno v:
Allergology International, Vol 68, Iss 1, Pp 59-67 (2019)
Background: Rupatadine, a novel nonsedating second-generation H1-antihistamine with antiplatelet-activating factor activity, has been used in the treatment of allergic rhinitis and urticaria in European countries since 2003. However, its efficacy and
Externí odkaz:
https://doaj.org/article/69e5236a4f7a4eba9ba3cde1072671d5
Autor:
Takeshi Matsumoto, Yumiko Sakurai, Takahiro Fujiki, Yusuke Kusakabe, Emi Nakayama, Ayaka Tanaka, Naoki Yamamoto, Kensaku Aihara, Shinpachi Yamaoka, Michiaki Mishima
Publikováno v:
Internal Medicine. 62:1219-1222
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6f3df5e938e7308efea85ecc9ec57878
https://doi.org/10.2169/internalmedicine.1169-22
https://doi.org/10.2169/internalmedicine.1169-22